• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性 α-突触核蛋白抗体复合物激活人诱导多能干细胞源性小胶质细胞中的 NLRP3 炎性体。

Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia.

机构信息

Neurodegeneration New Medicines Center, The Scripps Research Institute, La Jolla, CA 92037.

Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.

出版信息

Proc Natl Acad Sci U S A. 2021 Apr 13;118(15). doi: 10.1073/pnas.2025847118.

DOI:10.1073/pnas.2025847118
PMID:33833060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8054017/
Abstract

Parkinson's disease is characterized by accumulation of α-synuclein (αSyn). Release of oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via microglial activation. Heretofore, it remained unknown if oligomeric/fibrillar αSyn could activate the nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) family pyrin domain-containing 3 (NLRP3) inflammasome in human microglia and whether anti-αSyn antibodies could prevent this effect. Here, we show that αSyn activates the NLRP3 inflammasome in human induced pluripotent stem cell (hiPSC)-derived microglia (hiMG) via dual stimulation involving Toll-like receptor 2 (TLR2) engagement and mitochondrial damage. In vitro, hiMG can be activated by mutant (A53T) αSyn secreted from hiPSC-derived A9-dopaminergic neurons. Surprisingly, αSyn-antibody complexes enhanced rather than suppressed inflammasome-mediated interleukin-1β (IL-1β) secretion, indicating these complexes are neuroinflammatory in a human context. A further increase in inflammation was observed with addition of oligomerized amyloid-β peptide (Aβ) and its cognate antibody. In vivo, engraftment of hiMG with αSyn in humanized mouse brain resulted in caspase-1 activation and neurotoxicity, which was exacerbated by αSyn antibody. These findings may have important implications for antibody therapies aimed at depleting misfolded/aggregated proteins from the human brain, as they may paradoxically trigger inflammation in human microglia.

摘要

帕金森病的特征是α-突触核蛋白(αSyn)的积累。受损神经元中寡聚/纤维状αSyn 的释放可能会通过小胶质细胞的激活而增强神经元死亡。迄今为止,尚不清楚寡聚/纤维状αSyn 是否可以在人类小胶质细胞中激活核苷酸结合寡聚化结构域(NOD)样受体(NLR)家族富含pyrin 结构域的 3(NLRP3)炎性体,以及抗αSyn 抗体是否可以预防这种作用。在这里,我们表明 αSyn 通过涉及 Toll 样受体 2(TLR2)参与和线粒体损伤的双重刺激,在人诱导多能干细胞(hiPSC)衍生的小胶质细胞(hiMG)中激活 NLRP3 炎性体。在体外,hiMG 可被 hiPSC 衍生的 A9-多巴胺能神经元分泌的突变(A53T)αSyn 激活。令人惊讶的是,αSyn-抗体复合物增强而不是抑制炎性体介导的白细胞介素 1β(IL-1β)分泌,表明这些复合物在人类环境中具有神经炎症作用。与寡聚淀粉样β肽(Aβ)及其同源抗体一起添加时,会观察到炎症进一步增加。在体内,将携带 αSyn 的 hiMG 植入人源化小鼠大脑中会导致半胱天冬酶-1 的激活和神经毒性,而αSyn 抗体则会加剧这种毒性。这些发现对于旨在从人脑中耗尽错误折叠/聚集蛋白的抗体疗法可能具有重要意义,因为它们可能会在人类小胶质细胞中引发炎症。

相似文献

1
Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia.可溶性 α-突触核蛋白抗体复合物激活人诱导多能干细胞源性小胶质细胞中的 NLRP3 炎性体。
Proc Natl Acad Sci U S A. 2021 Apr 13;118(15). doi: 10.1073/pnas.2025847118.
2
Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.聚集的 α-突触核蛋白引发炎症小体,突触核蛋白病中的炎症反应。
PLoS One. 2013;8(1):e55375. doi: 10.1371/journal.pone.0055375. Epub 2013 Jan 31.
3
Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia.Fyn 激酶调节微胶质细胞中错误折叠的 α-突触核蛋白摄取和 NLRP3 炎性小体的激活。
J Exp Med. 2019 Jun 3;216(6):1411-1430. doi: 10.1084/jem.20182191. Epub 2019 Apr 29.
4
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.炎症小体抑制可预防小鼠 α-突触核蛋白病和多巴胺能神经退行性变。
Sci Transl Med. 2018 Oct 31;10(465). doi: 10.1126/scitranslmed.aah4066.
5
α-Synuclein evokes NLRP3 inflammasome-mediated IL-1β secretion from primary human microglia.α-突触核蛋白诱导原代人小胶质细胞中 NLRP3 炎性体介导的白细胞介素 1β 分泌。
Glia. 2021 Jun;69(6):1413-1428. doi: 10.1002/glia.23970. Epub 2021 Jan 28.
6
Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia.β-淀粉样蛋白通过 TLR4 在小鼠小胶质细胞中激活 NLRP3 炎性体。
Neurosci Lett. 2020 Sep 25;736:135279. doi: 10.1016/j.neulet.2020.135279. Epub 2020 Jul 26.
7
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson's disease.多巴胺信号调节小胶质细胞 NLRP3 炎症小体的激活:对帕金森病的影响。
J Neuroinflammation. 2022 Feb 16;19(1):50. doi: 10.1186/s12974-022-02410-4.
8
Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.靶向帕金森病中微胶质细胞α-突触核蛋白/TLRs/NF-κB/NLRP3 炎性小体轴
Front Immunol. 2021 Oct 8;12:719807. doi: 10.3389/fimmu.2021.719807. eCollection 2021.
9
p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.p38-TFEB 通路通过抑制 CMA 介导的 NLRP3 降解促进帕金森病小胶质细胞的激活。
J Neuroinflammation. 2021 Dec 20;18(1):295. doi: 10.1186/s12974-021-02349-y.
10
Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease.NLRP3 炎性小体激活的机制:在阿尔茨海默病治疗中的作用。
Neurochem Res. 2020 Nov;45(11):2560-2572. doi: 10.1007/s11064-020-03121-z. Epub 2020 Sep 14.

引用本文的文献

1
Hypoxia drives progression of multiple sclerosis by enhancing the inflammasome activation in macrophages with Porphyromonas gingivalis infection.缺氧通过增强牙龈卟啉单胞菌感染的巨噬细胞中的炎性小体激活来驱动多发性硬化症的进展。
Cell Death Discov. 2025 Jun 10;11(1):271. doi: 10.1038/s41420-025-02548-z.
2
Targeting mitochondria with natural polyphenols for treating Neurodegenerative Diseases: a comprehensive scoping review from oxidative stress perspective.从氧化应激角度出发,利用天然多酚靶向线粒体治疗神经退行性疾病:一项全面的范围综述
J Transl Med. 2025 May 23;23(1):572. doi: 10.1186/s12967-025-06605-0.
3
Emerging Insights into Brain Inflammation: Stem-Cell-Based Approaches for Regenerative Medicine.对脑炎症的新见解:基于干细胞的再生医学方法。
Int J Mol Sci. 2025 Apr 1;26(7):3275. doi: 10.3390/ijms26073275.
4
diAcCA, a Pro-Drug for Carnosic Acid That Activates the Nrf2 Transcriptional Pathway, Shows Efficacy in the 5xFAD Transgenic Mouse Model of Alzheimer's Disease.二乙酰基咖啡酸(diAcCA),一种可激活Nrf2转录途径的迷迭香酸前药,在阿尔茨海默病的5xFAD转基因小鼠模型中显示出疗效。
Antioxidants (Basel). 2025 Feb 28;14(3):293. doi: 10.3390/antiox14030293.
5
Identification and Exploration of Immunity-Related Genes and Natural Products for Alzheimer's Disease Based on Bioinformatics, Molecular Docking, and Molecular Dynamics.基于生物信息学、分子对接和分子动力学的阿尔茨海默病免疫相关基因及天然产物的鉴定与探索
Immun Inflamm Dis. 2025 Apr;13(4):e70166. doi: 10.1002/iid3.70166.
6
Proinflammatory cytokines, oxidative stress, and organ function as biomarkers of soman (GD) chronic neurotoxicity.促炎细胞因子、氧化应激和器官功能作为梭曼(GD)慢性神经毒性的生物标志物。
Sci Rep. 2025 Mar 15;15(1):9021. doi: 10.1038/s41598-025-94190-z.
7
Tim-3 Deficiency Ameliorates Motor Deficits and Neuroinflammation in MPP+/MPTP-Induced Parkinson's Disease Models via the NF-κB/NLRP3 Pathway.Tim-3缺陷通过NF-κB/NLRP3途径改善MPP+/MPTP诱导的帕金森病模型中的运动功能障碍和神经炎症。
Mol Neurobiol. 2025 May;62(5):5566-5578. doi: 10.1007/s12035-024-04560-3. Epub 2024 Nov 23.
8
Redox regulation, protein S-nitrosylation, and synapse loss in Alzheimer's and related dementias.氧化还原调节、蛋白质S-亚硝基化与阿尔茨海默病及相关痴呆中的突触丧失
Neuron. 2024 Dec 4;112(23):3823-3850. doi: 10.1016/j.neuron.2024.10.013. Epub 2024 Nov 7.
9
Modulating NLRP3 splicing with antisense oligonucleotides to control pathological inflammation.用反义寡核苷酸调节NLRP3剪接以控制病理性炎症。
bioRxiv. 2025 May 1:2024.09.06.611206. doi: 10.1101/2024.09.06.611206.
10
Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer's disease.炎性小体将创伤性脑损伤、慢性创伤性脑病和阿尔茨海默病联系起来。
Neural Regen Res. 2025 Jun 1;20(6):1644-1664. doi: 10.4103/NRR.NRR-D-24-00107. Epub 2024 Jul 10.

本文引用的文献

1
Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia.β-淀粉样蛋白通过 TLR4 在小鼠小胶质细胞中激活 NLRP3 炎性体。
Neurosci Lett. 2020 Sep 25;736:135279. doi: 10.1016/j.neulet.2020.135279. Epub 2020 Jul 26.
2
Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial.α-突触核蛋白活性免疫疗法PD01A在帕金森病患者中的安全性和免疫原性:一项随机、单盲、1期试验。
Lancet Neurol. 2020 Jul;19(7):591-600. doi: 10.1016/S1474-4422(20)30136-8.
3
Parkinson disease setback.帕金森病病情恶化
Nat Rev Drug Discov. 2020 Jun;19(6):373. doi: 10.1038/d41573-020-00090-4.
4
Amyloid-Beta (Aβ) Plaques Promote Seeding and Spreading of Alpha-Synuclein and Tau in a Mouse Model of Lewy Body Disorders with Aβ Pathology.淀粉样蛋白-β(Aβ)斑块促进路易体病伴 Aβ 病理学小鼠模型中α-突触核蛋白和 tau 的播种和扩散。
Neuron. 2020 Jan 22;105(2):260-275.e6. doi: 10.1016/j.neuron.2019.10.010. Epub 2019 Nov 20.
5
Stem-cell-derived human microglia transplanted in mouse brain to study human disease.将源自干细胞的人类小神经胶质细胞移植到老鼠大脑中,以研究人类疾病。
Nat Neurosci. 2019 Dec;22(12):2111-2116. doi: 10.1038/s41593-019-0525-x. Epub 2019 Oct 28.
6
The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease.先天免疫反应和神经炎症在淀粉样蛋白沉积和阿尔茨海默病进展中的作用。
Immunol Cell Biol. 2020 Jan;98(1):28-41. doi: 10.1111/imcb.12301. Epub 2019 Nov 20.
7
Murine iPSC-derived microglia and macrophage cell culture models recapitulate distinct phenotypical and functional properties of classical and alternative neuro-immune polarisation.鼠源 iPSC 衍生的小胶质细胞和巨噬细胞细胞培养模型重现了经典和替代神经免疫极化的独特表型和功能特性。
Brain Behav Immun. 2019 Nov;82:406-421. doi: 10.1016/j.bbi.2019.09.009. Epub 2019 Sep 13.
8
The physiological role of α-synuclein and its relationship to Parkinson's Disease.α-突触核蛋白的生理作用及其与帕金森病的关系。
J Neurochem. 2019 Sep;150(5):475-486. doi: 10.1111/jnc.14810. Epub 2019 Jul 28.
9
Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia.Fyn 激酶调节微胶质细胞中错误折叠的 α-突触核蛋白摄取和 NLRP3 炎性小体的激活。
J Exp Med. 2019 Jun 3;216(6):1411-1430. doi: 10.1084/jem.20182191. Epub 2019 Apr 29.
10
Immune Signaling in Neurodegeneration.神经退行性变中的免疫信号转导。
Immunity. 2019 Apr 16;50(4):955-974. doi: 10.1016/j.immuni.2019.03.016.